However, there have been attempts to combine CRP and NLR for other purposes, such as for predicting the prognosis in patients with gastric cancer23, non-small-cell lung cancer24, and in acute myocardial infarction patients undergoing percutaneous coronary intervention25, in patients with COVID-19 pneumonia26 and for diagnosing spontaneous bacterial peritonitis in cirrhotic patients27. This evidence concerns the gene CRP and myocardial infarction.